Nanoparticle delivery of VEGF-B mRNA promotes T cell infiltration within tumor and triggers robust antitumor immunity
The advancement of mRNA-based cancer immunotherapies has gained significant momentum, particularly after the success of mRNA vaccines during the COVID-19 pandemic and the recognition of mRNA vaccine development with the 2023 Nobel Prize. mRNA encoding cytokines, antibodies, and chimeric antigen rece...
Saved in:
| Main Authors: | Geqiang Zhang, Jun Tu, Yu Zhang, Jianli He, Guoyuan Peng, Qiuju Fan, Yirong Zhang, Mingming Zhang, Hongsheng Tan, Yingjie Xu, Jinke Cheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Molecular Therapy: Nucleic Acids |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S216225312500174X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plasma levels of the lymphangiogenic factors VEGF-C, VEGF-D, and CXCL-12 are elevated in advanced diabetic nephropathy
by: Qingshan Tian, et al.
Published: (2025-12-01) -
Antitumor mRNA vaccines based on neoantigens
by: E. V. Starostina, et al.
Published: (2025-01-01) -
Targeted mRNA delivery with bispecific antibodies that tether LNPs to cell surface markers
by: Bettina Dietmair, et al.
Published: (2025-06-01) -
A short peptide for efficient cellular mRNA delivery: A potential application for inducing an immune response
by: Clémentine Ayélé Teko-Agbo, et al.
Published: (2025-09-01) -
Expression of endothelin in experimental myocardial infarction in a changed concentration of FGF and VEGF
by: M. G. Shurygin, et al.
Published: (2013-02-01)